In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Sanofi ADR (NASDAQ: SNY) closed at $47.89 in the last session, up 1.46% from day before closing price of $47.2. In other words, the price has increased by $1.46 from its previous closing price. On the day, 2.54 million shares were traded. SNY stock price reached its highest trading level at $48.16 during the session, while it also had its lowest trading level at $47.75.
Ratios:
We take a closer look at SNY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.73. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 1.27. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.21.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNY now has a Market Capitalization of 116026900480 and an Enterprise Value of 71453810688. As of this moment, Sanofi’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.96, and their Forward P/E ratio for the next fiscal year is 9.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.68 while its Price-to-Book (P/B) ratio in mrq is 1.42. Its current Enterprise Value per Revenue stands at 1.556 whereas that against EBITDA is 5.793.
Stock Price History:
The Beta on a monthly basis for SNY is 0.43, which has changed by -0.069767416 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, SNY has reached a high of $60.12, while it has fallen to a 52-week low of $44.62. The 50-Day Moving Average of the stock is -2.52%, while the 200-Day Moving Average is calculated to be -3.41%.
Shares Statistics:
According to the various share statistics, SNY traded on average about 2.62M shares per day over the past 3-months and 3445400 shares per day over the past 10 days. A total of 2.43B shares are outstanding, with a floating share count of 2.42B. Insiders hold about 0.00% of the company’s shares, while institutions hold 9.87% stake in the company. Shares short for SNY as of 1767139200 were 7743573 with a Short Ratio of 2.95, compared to 1764288000 on 6252649. Therefore, it implies a Short% of Shares Outstanding of 7743573 and a Short% of Float of 0.36000002.
Dividends & Splits
The forward annual dividend rate for SNY is 2.21, which was 0.0 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.0. The stock’s 5-year Average Dividend Yield is 3.87.
Earnings Estimates
The firm’s stock currently is rated by 2.0 analysts. The consensus estimate for the next quarter is $0.99, with high estimates of $0.99 and low estimates of $0.99.
Analysts are recommending an EPS of between $4.78 and $4.44 for the fiscal current year, implying an average EPS of $4.56. EPS for the following year is $4.91, with 4.0 analysts recommending between $5.1 and $4.78.
Revenue Estimates
According to 4 analysts,. The current quarter’s revenue is expected to be $11.1B. It ranges from a high estimate of $11.18B to a low estimate of $11.02B. As of. The current estimate, Sanofi ADR’s year-ago sales were $10.56B
A total of 10 analysts have provided revenue estimates for SNY’s current fiscal year. The highest revenue estimate was $43.62B, while the lowest revenue estimate was $43.3B, resulting in an average revenue estimate of $43.44B. In the same quarter a year ago, actual revenue was $41.08BBased on 8 analysts’ estimates, the company’s revenue will be $46.35B in the next fiscal year. The high estimate is $47.3B and the low estimate is $45.36B.
